Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free BVC Stock Alerts

BATM Advanced Communications (BVC) Competitors

BATM Advanced Communications logo
GBX 12.98 +0.08 (+0.58%)
As of 04:01 AM Eastern
Compare

BVC vs. EKF, SPEC, CREO, IUG, and NCYT

Should you buy BATM Advanced Communications stock or one of its competitors? MarketBeat compares BATM Advanced Communications with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BATM Advanced Communications include EKF Diagnostics (EKF), INSPECS Group (SPEC), Creo Medical Group (CREO), Intelligent Ultrasound Group (IUG), and Novacyt (NCYT). These companies are all part of the "healthcare equipment & supplies" industry.

How does BATM Advanced Communications compare to EKF Diagnostics?

BATM Advanced Communications (LON:BVC) and EKF Diagnostics (LON:EKF) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, risk, profitability, dividends, earnings, valuation, institutional ownership and media sentiment.

BATM Advanced Communications has a beta of 0.754, suggesting that its stock price is 25% less volatile than the broader market. Comparatively, EKF Diagnostics has a beta of 0.513, suggesting that its stock price is 49% less volatile than the broader market.

In the previous week, EKF Diagnostics had 1 more articles in the media than BATM Advanced Communications. MarketBeat recorded 1 mentions for EKF Diagnostics and 0 mentions for BATM Advanced Communications. BATM Advanced Communications' average media sentiment score of 0.00 equaled EKF Diagnostics'average media sentiment score.

Company Overall Sentiment
BATM Advanced Communications Neutral
EKF Diagnostics Neutral

EKF Diagnostics has a net margin of 4.12% compared to BATM Advanced Communications' net margin of -14.90%. EKF Diagnostics' return on equity of 3.01% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
BATM Advanced Communications-14.90% -22.13% 0.58%
EKF Diagnostics 4.12%3.01%5.27%

16.6% of BATM Advanced Communications shares are owned by institutional investors. Comparatively, 22.0% of EKF Diagnostics shares are owned by institutional investors. 31.0% of BATM Advanced Communications shares are owned by company insiders. Comparatively, 40.0% of EKF Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

EKF Diagnostics has a consensus price target of GBX 35, indicating a potential upside of 38.06%. Given EKF Diagnostics' stronger consensus rating and higher probable upside, analysts clearly believe EKF Diagnostics is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
EKF Diagnostics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

EKF Diagnostics has lower revenue, but higher earnings than BATM Advanced Communications. BATM Advanced Communications is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BATM Advanced Communications£123.20M0.36-£278.26K-£4.20N/A
EKF Diagnostics£51.56M2.12£4.68M£0.4753.94

Summary

EKF Diagnostics beats BATM Advanced Communications on 13 of the 15 factors compared between the two stocks.

How does BATM Advanced Communications compare to INSPECS Group?

INSPECS Group (LON:SPEC) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings and dividends.

INSPECS Group has a net margin of -2.67% compared to BATM Advanced Communications' net margin of -14.90%. INSPECS Group's return on equity of -6.07% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.67% -6.07% 0.45%
BATM Advanced Communications -14.90%-22.13%0.58%

INSPECS Group has a beta of 1.607, indicating that its stock price is 61% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, indicating that its stock price is 25% less volatile than the broader market.

0.4% of INSPECS Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 19.6% of INSPECS Group shares are held by company insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, INSPECS Group's average media sentiment score of 0.99 beat BATM Advanced Communications' score of 0.00 indicating that INSPECS Group is being referred to more favorably in the media.

Company Overall Sentiment
INSPECS Group Positive
BATM Advanced Communications Neutral

INSPECS Group presently has a consensus target price of GBX 60, indicating a potential downside of 38.14%. Given INSPECS Group's stronger consensus rating and higher probable upside, research analysts plainly believe INSPECS Group is more favorable than BATM Advanced Communications.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
BATM Advanced Communications
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

BATM Advanced Communications has lower revenue, but higher earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than BATM Advanced Communications, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£191.70M0.55-£4.11M-£9.40N/A
BATM Advanced Communications£123.20M0.36-£278.26K-£4.20N/A

Summary

INSPECS Group beats BATM Advanced Communications on 9 of the 15 factors compared between the two stocks.

How does BATM Advanced Communications compare to Creo Medical Group?

Creo Medical Group (LON:CREO) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.

BATM Advanced Communications has higher revenue and earnings than Creo Medical Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Creo Medical Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Creo Medical Group£6M10.53-£25.04M£1.0013.00
BATM Advanced Communications£123.20M0.36-£278.26K-£4.20N/A

In the previous week, Creo Medical Group's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Creo Medical Group Neutral
BATM Advanced Communications Neutral

Creo Medical Group has a beta of 1.563854, indicating that its share price is 56% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, indicating that its share price is 25% less volatile than the broader market.

44.1% of Creo Medical Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 6.9% of Creo Medical Group shares are held by insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Creo Medical Group has a net margin of 88.33% compared to BATM Advanced Communications' net margin of -14.90%. Creo Medical Group's return on equity of 9.56% beat BATM Advanced Communications' return on equity.

Company Net Margins Return on Equity Return on Assets
Creo Medical Group88.33% 9.56% -20.09%
BATM Advanced Communications -14.90%-22.13%0.58%

Summary

Creo Medical Group beats BATM Advanced Communications on 7 of the 11 factors compared between the two stocks.

How does BATM Advanced Communications compare to Intelligent Ultrasound Group?

Intelligent Ultrasound Group (LON:IUG) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, profitability, earnings, media sentiment, dividends, analyst recommendations and valuation.

75.5% of Intelligent Ultrasound Group shares are held by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are held by institutional investors. 12.8% of Intelligent Ultrasound Group shares are held by insiders. Comparatively, 31.0% of BATM Advanced Communications shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Intelligent Ultrasound Group's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Intelligent Ultrasound Group Neutral
BATM Advanced Communications Neutral

BATM Advanced Communications has a net margin of -14.90% compared to Intelligent Ultrasound Group's net margin of -23.11%. BATM Advanced Communications' return on equity of -22.13% beat Intelligent Ultrasound Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Intelligent Ultrasound Group-23.11% -23.58% -13.51%
BATM Advanced Communications -14.90%-22.13%0.58%

BATM Advanced Communications has higher revenue and earnings than Intelligent Ultrasound Group. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Intelligent Ultrasound Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intelligent Ultrasound Group£6.57M0.00-£2.27M-£0.68N/A
BATM Advanced Communications£123.20M0.36-£278.26K-£4.20N/A

Intelligent Ultrasound Group has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, indicating that its stock price is 25% less volatile than the broader market.

Summary

BATM Advanced Communications beats Intelligent Ultrasound Group on 8 of the 10 factors compared between the two stocks.

How does BATM Advanced Communications compare to Novacyt?

Novacyt (LON:NCYT) and BATM Advanced Communications (LON:BVC) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

In the previous week, Novacyt's average media sentiment score of 0.00 equaled BATM Advanced Communications'average media sentiment score.

Company Overall Sentiment
Novacyt Neutral
BATM Advanced Communications Neutral

Novacyt has a beta of 1.105, indicating that its share price is 11% more volatile than the broader market. Comparatively, BATM Advanced Communications has a beta of 0.754, indicating that its share price is 25% less volatile than the broader market.

BATM Advanced Communications has higher revenue and earnings than Novacyt. BATM Advanced Communications is trading at a lower price-to-earnings ratio than Novacyt, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novacyt£20.03M1.32-£36.80M-£32.00N/A
BATM Advanced Communications£123.20M0.36-£278.26K-£4.20N/A

10.7% of Novacyt shares are owned by institutional investors. Comparatively, 16.6% of BATM Advanced Communications shares are owned by institutional investors. 0.4% of Novacyt shares are owned by insiders. Comparatively, 31.0% of BATM Advanced Communications shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

BATM Advanced Communications has a net margin of -14.90% compared to Novacyt's net margin of -103.08%. BATM Advanced Communications' return on equity of -22.13% beat Novacyt's return on equity.

Company Net Margins Return on Equity Return on Assets
Novacyt-103.08% -96.44% -27.98%
BATM Advanced Communications -14.90%-22.13%0.58%

Summary

BATM Advanced Communications beats Novacyt on 8 of the 11 factors compared between the two stocks.

Get BATM Advanced Communications News Delivered to You Automatically

Sign up to receive the latest news and ratings for BVC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BVC vs. The Competition

Export
MetricBATM Advanced CommunicationsHealthcare Equipment & Supplies IndustryHealthcare SectorLON Exchange
Market Cap£44.13M£5.69B£6.97B£2.88B
Dividend Yield3.52%1.78%2.59%6.11%
P/E Ratio-3.0924.70270.87368.45
Price / Sales0.3664.87666.6283,672.19
Price / Cash2.1232.4371.8927.89
Price / Book0.565.5513.297.27
Net Income-£278.26K£147.95M£3.45B£5.89B
7 Day Performance5.49%3.75%4.21%1.97%
1 Month Performance-10.52%-0.90%-1.96%1.63%
1 Year Performance-14.07%8.96%76.81%74.57%

BATM Advanced Communications Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BVC
BATM Advanced Communications
N/AGBX 12.98
+0.6%		N/A-21.8%£44.13M£123.20MN/A980
EKF
EKF Diagnostics
1.977 of 5 stars		GBX 25.82
+0.1%		GBX 35
+35.6%		-9.9%£111.10M£51.56M54.94356
SPEC
INSPECS Group
1.1 of 5 stars		GBX 97
flat		GBX 60
-38.1%		+115.6%£105.90M£191.70MN/A1,673
CREO
Creo Medical Group
N/AGBX 13.06
-1.4%		GBX 40
+206.3%		-4.9%£63.45M£6M13.06279
IUG
Intelligent Ultrasound Group
N/AN/AN/AN/A£42.76M£6.57MN/A65

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:BVC) was last updated on 8/7/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel